Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk

BACKGROUND: Metabolic syndrome (MetS) and insulin resistance (IR) are increasing in prevalence, are associated with higher risk for coronary heart disease (CHD), and may potentially influence the responses to lipid-altering drug therapy. This study evaluated the effects of MetS factors (abdominal ob...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lipids Health Dis
Main Authors: Rosen, Jeffrey B., Ballantyne, Christie M., Hsueh, Willa A., Lin, Jianxin, Shah, Arvind K., Lowe, Robert S., Tershakovec, Andrew M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559874/
https://ncbi.nlm.nih.gov/pubmed/26336957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-015-0075-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados